The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive Search, was retained by Genmab Pharmaceuticals to execute a critical executive search for their development leadership team. The expectation of an accelerated time frame for completion resulted in the successful placement of Claire Blanchette as Vice President, Compound Development Team Lead. Reporting directly to the EVP & Chief Development Officer, Blanchette’s well-rounded background will be crucial to oversee the solid tumors program, providing visionary leadership to team members. Blanchette’s role is instrumental in developing a highly effective international project team and supporting future expansion. It is a privilege to partner with Genmab and aid in their organizational growth as they strive to create and develop innovative products with the aim of improving the lives of cancer patients. The Chase Group never loses sight of how its services can profoundly impact the future success of an organization and appreciate a focused collaboration with Genmab. To learn how The Chase Group can identify high caliber talent for your team, please contact karen@chasegroup.com.
The Chase Group Continues Successful Collaboration with Genmab Through Placement of Vice President, CDTL
The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive Search, was retained by Genmab Pharmaceuticals to execute a critical executive search for their development leadership team. The expectation of an accelerated time frame for completion resulted in the successful placement of Claire Blanchette as Vice President, Compound Development Team Lead. Reporting directly to the EVP & Chief Development Officer, Blanchette’s well-rounded background will be crucial to oversee the solid tumors program, providing visionary leadership to team members. Blanchette’s role is instrumental in developing a highly effective international project team and supporting future expansion. It is a privilege to partner with Genmab and aid in their organizational growth as they strive to create and develop innovative products with the aim of improving the lives of cancer patients. The Chase Group never loses sight of how its services can profoundly impact the future success of an organization and appreciate a focused collaboration with Genmab. To learn how The Chase Group can identify high caliber talent for your team, please contact karen@chasegroup.com.
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike…
Arcturus Therapeutics Secures Head of Drug Safety Through Continued Partnership with The Chase Group
The Chase Group’s track record for success continues with another executive placement secured for Arcturus Therapeutics. Entering a new stage in clinical development, Arcturus retained…
Leadership Team Grows at Biologics Consulting Through Partnership with The Chase Group
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their leadership team. Tasked with identifying a Regulatory Project Management Lead,…-
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience…. -
The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development… 
Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership with The Chase Group
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…